Browse by category

Individuals treated with anti-obesity medications generally experience reduced appetite, which typically leads to reduced food intake. As...

Researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London, UK, have investigated the...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

The ten-year outcomes from the ’Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Biliopancreatic Diversion (BPD)- Duodenal...

Although glucagon-like peptide-1 receptor agonists (GLP-1RAs) are highly effective for weight management and Type 2 diabetes treatment,...

There are only mild differences in gastric emptying among patients taking glucagon-like peptide-1 (GLP-1) receptor agonist medications...

Glyscend Therapeutics has initiated a Phase 2 clinical trial of its lead candidate, GLY-200, as a novel oral treatment for obesity....

The type of bariatric surgery women undergo before becoming pregnant may affect how much weight their children gain in the first three...

Issue 52 of Bariatric News is now available to read and/or download. In this issue, we report one billion people living with obesity, we...

Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide,...